BC
MRTX

Brookfield Corp’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Brookfield Corp’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,607
Closed -$1.85M – 794
2021
Q4 		$1.85M Buy
+12,607
New +$1.85M 0.01% 331